Publications

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

par Debbie Cloake

Upgrading the single market: a unitary SPC?

par Dr Paul England

Facing up to antimicrobial resistance – recommendations from the O'Neill review

Largest damages award on cross-undertaking upheld on appeal

par Dr Paul England

Strategic considerations - why opt-out or why not?

par Dr. Anja Lunze, LL.M.

Pharmaceutical trade mark confusion

Using intellectual property protection

par Colin McCall

EU Commission regulates post-authorisation efficacy studies ("PAES")

par Dr. Wolfgang Rehmann

Personalised medicine – challenges of authorisation and reimbursement

par Dr. Manja Epping

There is more than one way to extend data exclusivity periods

par Edward Vickers

Companion diagnostics: legislation in progress

par Dr. Manja Epping

What the new Customs Regulation means in practice

par Roland Mallinson